Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MBRX | MOLECULIN BIOTECH INC | $13.90M | $0.27 | $100.00 | 36,530.04% | Buy | 2 | N/A | N/A | N/A | -1,076.69% | |||
| FBLG | FIBROBIOLOGICS INC | $14.10M | $0.27 | $10.00 | 3,549.64% | Strong Buy | 2 | N/A | N/A | -27,082.36% | -387.16% | |||
| KALA | KALA BIO INC | $7.93M | $0.97 | $32.67 | 3,281.68% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| CANF | CAN-FITE BIOPHARMA LTD | $4.17M | $0.35 | $6.75 | 1,828.57% | Strong Buy | 2 | 719.66% | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $76.53M | $0.78 | $13.50 | 1,628.55% | Buy | 4 | 596.43% | N/A | -17.23% | -12.96% | |||
| PMN | PROMIS NEUROSCIENCES INC | $14.55M | $6.76 | $112.50 | 1,564.20% | Strong Buy | 2 | N/A | N/A | -17.16% | -7.35% | |||
| NRXP | NRX PHARMACEUTICALS INC | $68.84M | $2.45 | $40.33 | 1,546.24% | Strong Buy | 3 | 1,160.38% | N/A | -556.39% | 955.57% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $155.12M | $0.46 | $7.00 | 1,418.44% | Buy | 3 | 48.30% | N/A | 842.99% | 59.37% | |||
| ACET | ADICET BIO INC | $99.31M | $0.65 | $8.50 | 1,211.73% | Strong Buy | 2 | N/A | N/A | -39.39% | -30.60% | |||
| KRRO | KORRO BIO INC | $53.68M | $5.70 | $74.17 | 1,201.18% | Buy | 6 | -58.86% | N/A | -72.89% | -44.68% | |||
| TVRD | TVARDI THERAPEUTICS INC | $38.65M | $4.12 | $53.60 | 1,200.97% | Strong Buy | 5 | N/A | N/A | -102.26% | -73.03% | |||
| PSTV | PLUS THERAPEUTICS INC | $83.83M | $0.61 | $7.25 | 1,088.52% | Strong Buy | 4 | 55.70% | N/A | -138.68% | -37.54% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $49.21M | $2.25 | $26.67 | 1,085.20% | Buy | 3 | 327.90% | N/A | N/A | -54.28% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $37.76M | $0.77 | $9.00 | 1,067.32% | Strong Buy | 2 | N/A | N/A | -330.30% | -89.97% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $370.12M | $3.42 | $39.50 | 1,054.97% | Buy | 8 | N/A | N/A | -36.95% | -31.49% | |||
| SKYE | SKYE BIOSCIENCE INC | $42.00M | $1.31 | $15.00 | 1,045.04% | Buy | 3 | N/A | N/A | -133.44% | -106.03% | |||
| LSTA | LISATA THERAPEUTICS INC | $18.17M | $2.06 | $23.50 | 1,040.78% | Strong Buy | 2 | 60.27% | N/A | -50.75% | -40.52% | |||
| GRI | GRI BIO INC | $6.54M | $2.00 | $22.50 | 1,025.00% | Buy | 2 | N/A | N/A | -59.63% | -24.85% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $13.56M | $1.26 | $14.00 | 1,011.11% | Buy | 2 | N/A | N/A | -45.75% | -39.13% | |||
| IFRX | INFLARX NV | $85.36M | $1.26 | $14.00 | 1,011.11% | Strong Buy | 2 | 215.41% | N/A | -69.43% | -48.34% | |||
| CING | CINGULATE INC | $25.20M | $3.73 | $39.00 | 945.58% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $63.03M | $1.79 | $18.50 | 933.52% | Strong Buy | 2 | N/A | N/A | -98.75% | -40.12% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $23.56M | $0.97 | $10.00 | 930.93% | Strong Buy | 2 | N/A | N/A | -133.24% | -111.24% | |||
| VNRX | VOLITIONRX LTD | $39.54M | $0.32 | $3.17 | 883.54% | Strong Buy | 3 | 249.16% | N/A | -283.89% | 1,524.72% | |||
| TIL | INSTIL BIO INC | $86.54M | $12.76 | $125.00 | 879.62% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ZSPC | ZSPACE INC | $12.35M | $0.43 | $4.00 | 841.18% | Strong Buy | 2 | 2.96% | N/A | N/A | -132.10% | |||
| SLN | SILENCE THERAPEUTICS PLC | $318.04M | $6.74 | $61.67 | 814.94% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $219.93M | $0.50 | $4.50 | 800.00% | Strong Buy | 2 | 506.84% | N/A | -1.88% | -1.30% | |||
| IMUX | IMMUNIC INC | $85.64M | $0.71 | $6.33 | 789.47% | Strong Buy | 3 | N/A | N/A | -147.22% | -37.97% | |||
| MYO | MYOMO INC | $34.21M | $0.89 | $7.67 | 761.46% | Buy | 3 | 12.85% | N/A | 18.58% | 7.97% | |||
| ONCY | ONCOLYTICS BIOTECH INC | $103.32M | $1.00 | $8.50 | 752.56% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CYBN | CYBIN INC | $142.34M | $6.18 | $50.00 | 709.06% | Strong Buy | 2 | N/A | N/A | -22.94% | -17.59% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $10.62M | $8.42 | $65.00 | 671.97% | Buy | 2 | N/A | N/A | -80.52% | -67.15% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $100.37M | $0.78 | $5.88 | 656.11% | Buy | 2 | N/A | N/A | -87.33% | -74.95% | |||
| BMEA | BIOMEA FUSION INC | $77.07M | $1.09 | $8.00 | 633.94% | Strong Buy | 5 | N/A | N/A | -503.29% | -142.44% | |||
| FEMY | FEMASYS INC | $59.06M | $1.01 | $7.25 | 617.82% | Strong Buy | 2 | 139.52% | N/A | -327.29% | -91.54% | |||
| AKTX | AKARI THERAPEUTICS PLC | $34.74M | $0.49 | $3.30 | 579.01% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| AMTX | AEMETIS INC | $113.43M | $1.73 | $11.50 | 564.74% | Strong Buy | 2 | 62.87% | N/A | -21.94% | 27.74% | |||
| CTSO | CYTOSORBENTS CORP | $50.93M | $0.81 | $5.38 | 562.76% | Buy | 2 | 21.50% | N/A | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $194.42M | $1.60 | $10.50 | 556.25% | Strong Buy | 2 | 82.19% | N/A | N/A | -574.54% | |||
| HUMA | HUMACYTE INC | $252.82M | $1.35 | $8.67 | 542.00% | Strong Buy | 6 | 285.88% | N/A | -8,282.35% | 430.01% | |||
| JSPR | JASPER THERAPEUTICS INC | $51.49M | $1.84 | $11.43 | 521.14% | Buy | 7 | N/A | N/A | -416.07% | -83.77% | |||
| NEUP | NEUPHORIA THERAPEUTICS INC | $24.31M | $4.52 | $28.00 | 519.47% | Strong Buy | 2 | -100.00% | N/A | -91.23% | -41.74% | |||
| NKTX | NKARTA INC | $134.25M | $1.89 | $11.67 | 517.30% | Strong Buy | 3 | N/A | N/A | -33.23% | -26.28% | |||
| CODX | CO-DIAGNOSTICS INC | $22.59M | $0.37 | $2.25 | 506.47% | Strong Buy | 2 | 296.19% | N/A | 73.29% | 65.25% | |||
| ULY | URGENTLY INC | $4.19M | $1.91 | $11.50 | 501.78% | Strong Buy | 2 | 12.54% | N/A | -34.61% | 36.60% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.